- Home
- NEGG vs NKTX Comparison
NEGG vs NKTX Comparison
Compare NEGG & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- NKTX
- Stock Information
- Founded
- NEGG 2001
- NKTX 2015
- Country
- NEGG United States
- NKTX United States
- Employees
- NEGG N/A
- NKTX N/A
- Industry
- NEGG Other Specialty Stores
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- NKTX Health Care
- Exchange
- NEGG Nasdaq
- NKTX Nasdaq
- Market Cap
- NEGG 122.3M
- NKTX 123.5M
- IPO Year
- NEGG 2010
- NKTX 2020
- Fundamental
- Price
- NEGG $36.22
- NKTX $1.84
- Analyst Decision
- NEGG
- NKTX Strong Buy
- Analyst Count
- NEGG 0
- NKTX 6
- Target Price
- NEGG N/A
- NKTX $14.40
- AVG Volume (30 Days)
- NEGG 720.9K
- NKTX 463.1K
- Earning Date
- NEGG 08-28-2025
- NKTX 08-12-2025
- Dividend Yield
- NEGG N/A
- NKTX N/A
- EPS Growth
- NEGG N/A
- NKTX N/A
- EPS
- NEGG N/A
- NKTX N/A
- Revenue
- NEGG $1,235,576,000.00
- NKTX N/A
- Revenue This Year
- NEGG N/A
- NKTX N/A
- Revenue Next Year
- NEGG N/A
- NKTX N/A
- P/E Ratio
- NEGG N/A
- NKTX N/A
- Revenue Growth
- NEGG N/A
- NKTX N/A
- 52 Week Low
- NEGG $3.32
- NKTX $1.31
- 52 Week High
- NEGG $56.00
- NKTX $8.23
- Technical
- Relative Strength Index (RSI)
- NEGG 68.80
- NKTX 51.45
- Support Level
- NEGG $15.31
- NKTX $1.68
- Resistance Level
- NEGG $56.00
- NKTX $1.84
- Average True Range (ATR)
- NEGG 5.67
- NKTX 0.08
- MACD
- NEGG 2.67
- NKTX 0.01
- Stochastic Oscillator
- NEGG 56.85
- NKTX 80.95
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.